These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24374416)

  • 1. Prevalent but moderate variation across small geographic regions in patient nonadherence to evidence-based preventive therapies in older adults after acute myocardial infarction.
    Fang G; Robinson JG; Lauffenburger J; Roth MT; Brookhart MA
    Med Care; 2014 Mar; 52(3):185-93. PubMed ID: 24374416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence Tradeoff to Multiple Preventive Therapies and All-Cause Mortality After Acute Myocardial Infarction.
    Korhonen MJ; Robinson JG; Annis IE; Hickson RP; Bell JS; Hartikainen J; Fang G
    J Am Coll Cardiol; 2017 Sep; 70(13):1543-1554. PubMed ID: 28935030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonadherence to Statins and Antihypertensives and Hospitalizations Among Elderly Medicare Beneficiaries With Incident Cancer.
    Chopra I; Dwibedi N; Mattes MD; Tan X; Findley P; Sambamoorthi U
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1351-1360. PubMed ID: 29118227
    [No Abstract]   [Full Text] [Related]  

  • 4. How Medicare Part D benefit phases affect adherence with evidence-based medications following acute myocardial infarction.
    Stuart B; Davidoff A; Erten M; Gottlieb SS; Dai M; Shaffer T; Zuckerman IH; Simoni-Wastila L; Bryant-Comstock L; Shenolikar R
    Health Serv Res; 2013 Dec; 48(6 Pt 1):1960-77. PubMed ID: 23742013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction.
    Lauffenburger JC; Robinson JG; Oramasionwu C; Fang G
    Circulation; 2014 Feb; 129(7):754-63. PubMed ID: 24326988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G; Annis IE; Farley JF; Mahendraratnam N; Hickson RP; Stürmer T; Robinson JG
    Pharmacotherapy; 2018 Jan; 38(1):29-41. PubMed ID: 29059475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Socio-demographic differences in adherence to evidence-based drug therapy after hospital discharge from acute myocardial infarction: a population-based cohort study in Rome, Italy.
    Kirchmayer U; Agabiti N; Belleudi V; Davoli M; Fusco D; Stafoggia M; Arcà M; Barone AP; Perucci CA
    J Clin Pharm Ther; 2012 Feb; 37(1):37-44. PubMed ID: 21294760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Timing of First Postdischarge Follow-up and Medication Adherence After Acute Myocardial Infarction.
    Faridi KF; Peterson ED; McCoy LA; Thomas L; Enriquez J; Wang TY
    JAMA Cardiol; 2016 May; 1(2):147-55. PubMed ID: 27437885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Hospitalization for Acute Myocardial Infarction on Adherence to Statins Among Older Adults.
    Kronish IM; Ross JS; Zhao H; Muntner P
    Circ Cardiovasc Qual Outcomes; 2016 Jul; 9(4):364-71. PubMed ID: 27220368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults.
    Zuckerman IH; Yin X; Rattinger GB; Gottlieb SS; Simoni-Wastila L; Pierce SA; Huang TY; Shenolikar R; Stuart B
    J Am Geriatr Soc; 2012 Oct; 60(10):1854-61. PubMed ID: 23003000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic polytherapy after myocardial infarction: the trade-off between hospital and community-based providers in determining adherence to medication.
    Di Martino M; Alagna M; Lallo A; Gilmore KJ; Francesconi P; Profili F; Scondotto S; Fantaci G; Trifirò G; Isgrò V; Davoli M; Fusco D
    BMC Cardiovasc Disord; 2021 Apr; 21(1):180. PubMed ID: 33853534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term medication adherence after myocardial infarction: experience of a community.
    Shah ND; Dunlay SM; Ting HH; Montori VM; Thomas RJ; Wagie AE; Roger VL
    Am J Med; 2009 Oct; 122(10):961.e7-13. PubMed ID: 19560749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of adherence to evidence-based therapy after acute myocardial infarction.
    Hamood H; Hamood R; Green MS; Almog R
    Eur J Prev Cardiol; 2016 Jun; 23(9):975-85. PubMed ID: 26198723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S; Jortveit J; Hasvold P; Thuresson M; Øie E
    BMC Cardiovasc Disord; 2016 May; 16():115. PubMed ID: 27246583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Difference in Medication Adherence Between Patients Prescribed a 30-Day Versus 90-Day Supply After Acute Myocardial Infarction.
    Rymer JA; Fonseca E; Bhandary DD; Kumar D; Khan ND; Wang TY
    J Am Heart Assoc; 2021 Jan; 10(1):e016215. PubMed ID: 33342227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Patient Enrollment in Medicare Part D With Outcomes After Acute Myocardial Infarction.
    Goyal A; de Lemos JA; Peng SA; Thomas L; Amsterdam EA; Hockenberry JM; Peterson ED; Wang TY
    Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):567-75. PubMed ID: 26508667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S; Abildstrom SZ; Rasmussen JN; Gislason GH; Schramm TK; Folke F; Køber L; Torp-Pedersen C; Madsen M
    Med Care; 2008 Jan; 46(1):70-7. PubMed ID: 18162858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S; Glynn RJ; Avorn J; Levin R; Winkelmayer WC
    Am J Cardiol; 2007 Oct; 100(7):1061-7. PubMed ID: 17884362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disability, race/ethnicity, and medication adherence among Medicare myocardial infarction survivors.
    Zhang Y; Baik SH; Chang CC; Kaplan CM; Lave JR
    Am Heart J; 2012 Sep; 164(3):425-433.e4. PubMed ID: 22980311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.